FDA NDC Directory · JSON-LD · Markdown

dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate

NDC 70010-031 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerGranules Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA217027
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsAMPHETAMINE ASPARTATE MONOHYDRATE (3.75 mg/1)
AMPHETAMINE SULFATE (3.75 mg/1)
DEXTROAMPHETAMINE SACCHARATE (3.75 mg/1)
DEXTROAMPHETAMINE SULFATE (3.75 mg/1)
Marketing started20230220
Package count1

External sources

Source: openFDA. Public-domain (CC0).